IRCT20200825048515N49 IRCT 2021-12-25 Esfahan University of Medical Sciences Evaluation of the effect of edible herbal medicine in decreasing mortality and hospitalization of patients with COVID-19. Evaluation of the effect of edible herbal medicine (containing Colchicum autumnale, Olea Europaea, Nigella sativa, Lavandula angustifolia, Zingiber officinale) in decreasing mortality and hospitalization duration in a severe and critical phase of patients with COVID-19. 2022-01-21 anticipated 150 Complete https://irct.ir/trial/60825 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: 150 eligible patients will be randomly selected. These people are then coded with the help of random allocation computer software and are automatically divided into two groups. The relevant codes will be entered in the raw checklists and each of these checklists will be assigned to a patient and that patient will be randomly studied in one of the two groups. 3 COVID-19. Intervention 1: Intervention group: Patients in this group receive standard treatment. In addition, they will be prescribed 2 one-gram oral capsules every 8 hours. The capsules contain 500 mg of honey and 500 mg of oily extract of the plant compounds (including containing Colchicum autumnale, Olea Europaea, Nigella sativa, Lavandula angustifolia, Zingiber officinale) in equal proportions. Intervention 2: Control group: Patients in this group will receive only standard treatments (including oxygen therapy, antiviral drugs, corticosteroids, anticoagulants and, if necessary, tocilizumab). No - There is not a plan to make this available Justification or reason for not sharing IPD is There is no further information